कृपया अन्य खोज का प्रयास करें
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company develops navacaprant (NMRA-140), a novel once-daily oral kappa opioid receptor antagonist, which is in phase 3 clinical trials for the treatment of major depressive disorder. It also develops NMRA-511 that is in phase 1 clinical trials in patients with agitation associated with dementia due to Alzheimer’s disease; and NMRA-266, which is in the phase 1 clinical trial for the treatment of schizophrenia and other neuropsychiatric disorders. In addition, its preclinical phase product includes NMRA-NMDA for the treatment of schizophrenia; NMRA-CK1d, a CK1d inhibitor program for the treatment of amyotrophic lateral sclerosis; NMRA-NLRP3 for the treatment of certain neurodegenerative conditions; and NMRA-GCase for the treatment of Parkinson’s disease. The company was formerly known as RBNC Therapeutics, Inc. and changed its name to Neumora Therapeutics, Inc. in October 2021. Neumora Therapeutics, Inc. was incorporated in 2019 and is headquartered in Watertown, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Gaurav Singal | - | - | Member of Technology Advisory Board |
Patrick Sullivan | - | - | Member of Scientific Advisory Board |
Kristina M. Burow | 51 | 2020 | Independent Director |
Diego A. Pizzagalli | - | - | Member of Technology Advisory Board |
John D. Murray | - | - | Member of Technology Advisory Board |
Sandeep Robert Datta | - | - | Member of Scientific Advisory Board |
Andrew Trister | - | - | Member of Technology Advisory Board |
Mark Daly | - | - | Member of Scientific Advisory Board |
Richard Huganir | - | - | Member of Scientific Advisory Board |
Iain McFadyen | - | - | Member of Technology Advisory Board |
Edward Roberts | - | - | Member of Scientific Advisory Board |
Benjamin Neale | - | - | Member of Scientific Advisory Board |
John Krystal | - | - | Member of Scientific Advisory Board |
Maykin Ho | 71 | 2021 | Independent Director |
Alex Wiltschko | - | 2023 | Member of Technology Advisory Board |
Hugh Rosen | 65 | - | Member of Scientific Advisory Board |
Beth Stevens | - | - | Member of Scientific Advisory Board |
Alan Anticevic | - | - | Member of Technology Advisory Board |
Paul L. Berns | 57 | 2020 | Co-Founder & Executive Chairman |
Matthew K. Fust | 59 | 2020 | Independent Director |
Bernardo L. Sabatini | - | - | Member of Scientific Advisory Board |
David A. Piacquad | 67 | 2023 | Independent Director |
Morgan H. Sheng | 66 | - | Member of Scientific Advisory Board |
Alaa Halawa | 41 | 2022 | Independent Director |
Edward M. Scolnick | 83 | - | Member of Scientific Advisory Board |
Henry O. Gosebruch | 51 | 2023 | President, CEO & Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है